AOBiome Therapeutic Product Pipeline

Therapeutic Product Pipeline

AOBiome LLC is developing first-in-class biological therapies for the treatment of both local and systemic inflammatory conditions. Unlike most other bacterial therapeutic products in development, we are deploying a single strain of bacteria in various dosing strengths which allows for a greatly streamlined manufacturing process. In addition, by leveraging our expertise in manufacturing our consumer products as well as the outstanding safety profile of our bacteria we have been able to focus on efficacy in our early stage trials.

AOBiome currently has two Phase 2 trials underway: one for the treatment of stage 1 and pre-hypertensive patients and one for the treatment of acne vulgaris. Additional INDs have either been filed or are in preparation for additional indications with clinical trials anticipated to start in Q3 of 2017.

Our Current Clinical Trials

   Hypertension: Veristat
  • Discovery
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Mild to Moderate Acne
  • Hypertension
  • Allergic Rhinitis
  • Pruritis/Eczema